On December 3, 2018 CAIRE is hosting a day-long Vaccine and Immunization Research Symposium to be held at the Shaw Centre in Ottawa, Ontario. We invite researchers to submit abstracts for 15 minute long oral presentations on topics ranging from vaccine development through implementation, and everything in between!
SUBMISSION OF ABSTRACTS
Abstracts demonstrating state-of-the-art Canadian research in the following areas are to be submitted in a WORD document to Gordean Bjornson at firstname.lastname@example.org by June 27, 2018:
- Laboratory Vaccinology including pre-clinical vaccine development, immunology and basic science;
- Clinical Vaccinology including methodology, pre-licensure epidemiology of vaccine preventable diseases, clinical trials, new vaccines and vaccine safety;
- Program Evaluation and Research including social science, economics, modelling and programmatic issues (process evaluation, vaccine coverage, post-marketing surveillance, disease impact);
Abstracts are to be submitted in English, and should not exceed 300 words (excluding title and authors).
Submitted abstracts must NOT have been previously presented in Canada or published. Data that is in press is acceptable. First/presenting author may only submit 1 abstract.
Abstracts can be submitted to both the CIC2018 and CAIRE Research Symposium but can only be presented at one of the events. If your abstract is accepted for both, you must select 1 event at which to present.
Submitters of abstracts will be notified by August 9, 2018.
FORMAT OF ABSTRACTS
Title – Be as brief and explicit as possible. Do not use abbreviations or acronyms in the title.
Contact Information – Include your full email address and telephone number.
Name(s) of Author(s) – Provide the name of each author (first and last name). Provide the affiliation(s) of the author(s) (organization, city, province). A maximum of three affiliations is permitted for each co-author.
Please use the following format, indicating in bold the four parts of your abstract:
- Limit the text to 300 words (excluding title and authors)
- Use subtitles to mark the parts of the abstract;
- Introduction/Hypothesis – provide necessary background to the problem/issue under investigation and clearly state the hypothesis
- Methods – methods used to address the hypothesis
- Results – interim results at time of submission are acceptable, but must be identified as interim. Results can be updated for the presentations.
- Conclusions/recommendations – a summary of your findings
- Always define abbreviations and acronyms.
- Data tables are permitted where required, but should be kept brief. Each table will count as 75 words against the 300 word limit.
CRITERIA AND GUIDELINES FOR ABSTRACT EVALUATION
The following criteria will be used to evaluate the abstracts:
- Significance & originality of the research
- Clear statement of testable objective(s) or purpose
- Appropriate methods
- Results must be available at the time of submission, if interim results this must clearly be indicated
- Conclusions clearly stemming from results
- Clarity of the abstract